Loading clinical trials...
Loading clinical trials...
An Open-label Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of CP-690,550 In Pediatric Patients From 2 To Less Than 18 Years Of Age With Juvenile Idiopathic Arthritis (JIA)
Conditions
Interventions
CP-690,550
CP-690,550
+1 more
Locations
10
United States
Explorer Clinic, University of Minnesota Children's Hospital
Minneapolis, Minnesota, United States
Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only)
Minneapolis, Minnesota, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Randall Children's Hospital at Legacy Emanuel
Portland, Oregon, United States
PRI - Pediatric Rheumatology Research Institute GmbH
Bad Bramstedt, Germany
Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek
Hamburg, Germany
Start Date
March 1, 2013
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
July 4, 2016
NCT06870045
NCT04902807
NCT04833465
NCT07000916
NCT06007456
NCT05572424
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions